Biogen Inc

{ "date": [ "202612", "202712", "202812" ], "revenue_estimate": [ 9487.1, 9421.27, 9505.51 ], "ebit_estimate": [ 2875.74, 2938.35, 3042.12 ], "ebitda_estimate": [ 3279.77, 3186.48, 3279.03 ], "net_income_estimate": [ 2288.07, 2414.33, 2549.16 ], "per_share_eps_estimate": [ 11.88, 12.43, 14.3 ], "eps_nri_estimate": [ 15.73, 16.37, 17.32 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ 138.24, 144.19, 165.36 ], "pretax_income_estimate": [ 2752.79, 2885.5, 3043.25 ], "operating_cash_flow_per_share_estimate": [ 22.39, 14.9, 19.75 ], "roa_estimate": [ 6.4, 6.05, 5.95 ], "roe_estimate": [ 11.7, 10.67, 9.69 ], "gross_margin_estimate": [ 77.12, 77.2, 77.63 ], "operating_cash_flow_estimate": [ 3314.05, 2204.67, 2922.53 ], "pettm_estimate": [ 14.5, 13.86, 12.05 ], "long_term_growth_rate_mean": 4.24, "long_term_revenue_growth_rate_mean": "-1.25", "future_per_share_eps_estimate_growth": 16.25, "future_eps_nri_estimate_growth": 4.24, "future_revenue_estimate_growth": -1.25, "future_ebit_estimate_growth": 16.84, "future_ebitda_estimate_growth": 6.85, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.25, "future_pretax_income_estimate_growth": 22.86, "future_book_value_per_share_estimate_growth": 9.38, "future_roa_estimate_growth": 8.13, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.77, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202603", "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 2239.95, 2404.04, 2417.53, 2399.15, 2273.63, 2454.08, 2461.33, 2445.3 ], "ebit_estimate": [ 526, 761.97, 768.97, 713.86, 563.98, 736.21, 719.7, 708.77 ], "ebitda_estimate": [ 618.53, 787.35, 813.43, 877.48, null, null, null, null ], "net_income_estimate": [ 444.11, 635.98, 637.76, 594.64, 488.57, 633.46, 619.16, 610.43 ], "per_share_eps_estimate": [ 2.46, 3.49, 3.58, 3.27, 2.71, 2.99, 3.06, 3.11 ], "eps_nri_estimate": [ 3.07, 4.31, 4.28, 4.07, 3.65, 4.5, 4.32, 4.54 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 127.4, 130.9, 134.6, 138.7, null, null, null, null ], "pretax_income_estimate": [ 538.67, 765.53, 762.78, 708.41, 532.6, 777, 749.85, 734.2 ], "operating_cash_flow_per_share_estimate": [ 4.02, 4.5, 4.95, 3.18, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 76.61, 77.82, 78.17, 78.39, 72, 72.5, 72.5, 73 ], "operating_cash_flow_estimate": [ 594.22, 666, 731.86, 470.15, null, null, null, null ], "pettm_estimate": [ 13.46, 13.2, 13.74, 14.33, 14.54, null, null, null ], "long_term_growth_rate_mean": 4.24, "long_term_revenue_growth_rate_mean": "-1.25", "future_per_share_eps_estimate_growth": 16.25, "future_eps_nri_estimate_growth": 4.24, "future_revenue_estimate_growth": -1.25, "future_ebit_estimate_growth": 16.84, "future_ebitda_estimate_growth": 6.85, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.25, "future_pretax_income_estimate_growth": 22.86, "future_book_value_per_share_estimate_growth": 9.38, "future_roa_estimate_growth": 8.13, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.77, "future_operating_cash_flow_per_share_estimate_growth": null }